Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001048359 | SCV001212360 | uncertain significance | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2024-12-28 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 477 of the CACNA1A protein (p.Arg477His). This variant is present in population databases (rs755107633, gnomAD 0.01%). This missense change has been observed in individual(s) with idiopathic epilepsy (PMID: 21703448). ClinVar contains an entry for this variant (Variation ID: 845317). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt CACNA1A protein function with a positive predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV001570122 | SCV001794343 | likely benign | not provided | 2019-05-17 | criteria provided, single submitter | clinical testing | Reported as a novel variant in a cohort of epilepsy patients; additional information was not provided (Klassen et al., 2011); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 28488083, 21703448) |
Athena Diagnostics | RCV001570122 | SCV002770831 | uncertain significance | not provided | 2022-03-31 | criteria provided, single submitter | clinical testing |